Gainline Capital Partners has acquired ANA Global, a manufacturer of plastic and metal components used by OEMs operating in the medical, automotive, and industrial sectors.
ANA Global specializes in plastic injection molding and metal stamping of engineered plastic housings, precision metal assemblies, and other hybrid components used in medical devices, interior automotive systems, and industrial equipment.
In addition to its San Diego headquarters, the company operates five facilities in Tijuana (3), Nogales, and Irapauto, Mexico. ANA Global was founded in Japan in 1953 and relocated its San Diego headquarters in 1987.
With the closing of the acquisition, Gainline has announced a new senior management team for ANA Global, appointing Richard Warren as CEO, Rafael Beverido as CFO, and Homero Escandón as COO. Mr. Warren has over 25 years of experience from roles at medical device makers Resolve Surgical Technologies, MMT, LISI, and at aerospace, automotive, and industrial component maker GKN. ANA Global’s former CEO and co-founder MD Hoque has retired from the business but remains an advisor to the board of directors.
“What impressed us most is ANA’s decades-long relationships with blue-chip customers and a culture that prioritizes quality and partnership,” said Mr. Warren. “We’re excited to build upon the strong foundation the ANA team has created, broaden the product set — particularly in engineered plastics and precision metal assemblies — and execute upon a compelling multi-year growth plan as we invest in capacity, automation, and new markets.”
Contract manufacturing in medical devices is a strong growth story. According to a June 2025 report from Meticulous Research, the global market is expected to grow from around $85 billion in 2025 to over $171 billion by 2032, driven by higher R&D spend, outsourcing of complex manufacturing, and demand for cost-effective scale. According to Nova Advisor, U.S. demand is even more aggressive, with the market projected to nearly quadruple by 2034, climbing from about $17 billion to $62 billion.
At the same time, nearshoring is no longer just a trend—it’s a strategic move. According to a June 2025 article in MPO Magazine, Nearshoring in the Medtech Markets, supply chain risk, rising labor costs in Asia, and regulatory complexity are pushing OEMs to build out regionalized supply networks. That’s especially true in medtech, where tighter collaboration between engineering and production teams matters. OEMs want partners who are close by, fast to respond, and fully equipped to handle precision work at scale—exactly where ANA fits in.
“Rich, Rafael, and Homero bring tremendous experience and a proven track record of scaling businesses,” said Rick Sullivan, a managing partner at Gainline. “This marks the beginning of an exciting new chapter for ANA.”
Gainline Capital makes control investments in U.S.-based manufacturing, business services, and industrial companies with EBITDA from $5 million to $50 million. The firm specializes in first institutional capital opportunities, with focus sectors including business services, niche manufacturing, consumer, logistics and transportation services.
“We’re thrilled to partner with ANA and build on its legacy as a trusted partner to global OEMs,” added Zach Greenspan, a vice president at Gainline. “We see tremendous opportunity to accelerate growth, expand capabilities, and capitalize on the macro nearshoring trend.”
In July 2023, Gainline held a final, above-target, oversubscribed, and hard-cap close of its second fund, Gainline Equity Fund II LP, with $400 million in capital. The fund’s original target was $300 million. Gainline’s earlier fund, Gainline Equity Fund LP, closed in 2019 with $155 million in capital. Gainline was founded in 2015 and is headquartered in Stamford, Connecticut.
© 2025 Private Equity Professional | October 17, 2025
